Retraction Note to: Protein–Protein Interaction Network Analysis in Chronic Obstructive Pulmonary Disease (Lung, 192, 87-93 DOI 10.1007/s00408-013-9509-x);Protein-protein interaction network analysis in chronic obstructive pulmonary disease

Lung

Volumn 192, Issue 1, 2014, Pages 87-93

  Bao, Hong ^a   Wang, Jiaman ^a   Zhou, Ding ^a   Han, Zhaoyong ^a   Su, Ling ^a   Zhang, Yuan ^a   Ye, Xiong ^a   Xu, Chunyan ^a   Wang, Yuping ^a   Li, Qinghua ^a  

^a FUDAN UNIVERSITY PUDONG MEDICAL CENTER   (China)

Author keywords

Connectivity map; COPD; Differentially expressed genes (DEGs); Protein protein interaction

Indexed keywords

CARDIAC GLYCOSIDE; DISULFIRAM; HELVETICOSIDE; LANATOSIDE C; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA BASE; DOWN REGULATION; DRUG POTENCY; DRUG TARGETING; EMBRYO; ERYTHROID PRECURSOR CELL; FETUS; FETUS LIVER; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN GENOME; KLF1 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; UPREGULATION;

CASE-CONTROL STUDIES; DATA MINING; DATABASES, GENETIC; DIGITALIS GLYCOSIDES; DISULFIRAM; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LANATOSIDES; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROPHANTHINS;

EID: 84894064310     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9786-7     Document Type: Erratum

References (40)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532-555
2. Murphy TF, Sethi S (2002) Chronic obstructive pulmonary disease. Drugs Aging 19(10):761-775
3. Petty TL (2003) Definition, epidemiology, course, and prognosis of COPD. Clin Cornerstone 5(1):1-10
4. Abramson M, Matheson M, Wharton C, Sim M (2002) Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults. Respirology 7(4):325-331
5. Hammond T, Ford A, de Bravo BF, Cote J (2012) Chronic obstructive pulmonary disease (COPD) and lung cancer. http://www.stopcancerfund.org/p-lung- cancer/copd-and-lung-cancer/
6. Nazir SA, Erbland ML (2009) Chronic obstructive pulmonary disease (COPD). Drugs Aging 26(10):813-831
7. Barnes PJ (2002) New treatments for COPD. Nat Rev Drug Discov 1(6):437-446
8. Berndt A, Leme AS, Shapiro SD (2012) Emerging genetics of COPD. EMBO Mol Med 4(11):1144-1155
9. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AMK (2004) Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 101(41):14895-14900
10. Gan W, Man S, Senthilselvan A, Sin D (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59(7):574-580
11. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33(20):e175
12. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264
13. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27(12):1739-1740. doi: 10.1093/bioinformatics/btr260
14. Cantu E, Lederer D, Meyer K, Milewski R, Suzuki Y, Shah R, Diamond J, Meyer N, Tobias J, Baldwin D (2013) Gene set enrichment analysis of bronchial alveolar lavage fluid identifies key innate immune pathways in primary graft dysfunction after lung transplantation. J Heart Lung Transpl 32(4):S41-S42
15. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(Database issue):D561-D568. doi: 10.1093/nar/gkq973
16. Enright AJ, Van Dongen S, Ouzounis CA (2002) An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 30(7):1575-1584
17. Maere S, Heymans K, Kuiper M (2005) BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21(16):3448-3449
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498-2504
19. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929-1935
20. Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95(26):15623-15628
21. Sana TR, Janatpour MJ, Sathe M, McEvoy LM, McClanahan TK (2005) Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29(6):256-269
22. Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El-Assal O, Gao B (2002) Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 122(4):1020-1034
23. Pilon AM, Arcasoy MO, Dressman HK, Vayda SE, Maksimova YD, Sangerman JI, Gallagher PG, Bodine DM (2008) Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol Cell Biol 28(24):7394-7401. doi: 10.1128/MCB.01087-08
24. Lee YJ, Kim NS, Kim H, Yi JM, Oh SM, Bang OS, Lee J (2013) Cytotoxic and anti-inflammatory constituents from the seeds of Descurainia sophia. Arch Pharmacol Res 36(5):536-541
25. Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafstrom RC, Perala M, Kallioniemi O (2009) High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res 15(19):6070-6078. doi: 10.1158/1078-0432.CCR-09-1035
26. Lin J, Haffner MC, Zhang Y, Lee BH, Brennen WN, Britton J, Kachhap SK, Shim JS, Liu JO, Nelson WG, Yegnasubramanian S, Carducci MA (2011) Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate 71(4):333-343. doi: 10.1002/pros.21247
27. Badr CE, Wurdinger T, Nilsson J, Niers JM, Whalen M, Degterev A, Tannous BA (2011) Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway. Neuro Oncol 13(11):1213-1224. doi: 10.1093/neuonc/nor067
28. MacNee W (2005) Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(4):258-266 discussion 290-291
29. Mallia P, Message SD, Kebadze T, Parker HL, Kon OM, Johnston SL (2006) An experimental model of rhinovirus-induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res 7:116
30. Gaajetaan GR, Geelen TH, Vernooy JH, Dentener MA, Reynaert NL, Rohde GG, Beuken EV, Grauls GE, Bruggeman CA, Stassen FR (2013) Interferon-beta induces a long-lasting antiviral state in human respiratory epithelial cells. J Infect 66(2):163-169. doi: 10.1016/j.jinf.2012.11.008
31. Southworth T, Metryka A, Lea S, Farrow S, Plumb J, Singh D (2012) IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation. Br J Pharmacol 166(7):2070-2083. doi: 10.1111/j.1476-5381.2012.01907.x
32. Bakke PS, Zhu G, Gulsvik A, Kong X, Agusti AG, Calverley PM, Donner CF, Levy RD, Make BJ, Pare PD, Rennard SI, Vestbo J, Wouters EF, Anderson W, Lomas DA, Silverman EK, Pillai SG (2011) Candidate genes for COPD in two large data sets. Eur Respir J 37(2):255-263. doi: 10.1183/09031936.00091709
33. Wang Q, Nagarkar DR, Bowman ER, Schneider D, Gosangi B, Lei J, Zhao Y, McHenry CL, Burgens RV, Miller DJ, Sajjan U, Hershenson MB (2009) Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 183(11):6989-6997. doi: 10.4049/jimmunol.0901386
34. Fujino N, Ota C, Takahashi T, Suzuki T, Suzuki S, Yamada M, Nagatomi R, Kondo T, Yamaya M, Kubo H (2012) Gene expression profiles of alveolar type II cells of chronic obstructive pulmonary disease: a case-control study. BMJ Open. doi: 10.1136/bmjopen-2012-001553
35. Holownia A, Mroz RM, Skopinski T, Kolodziejczyk A, Chyczewska E, Braszko JJ (2013) Tiotropium increases PPAR gamma and decreases CREB in cells isolated from induced sputum of COPD patients. Adv Exp Med Biol 756:9-14. doi: 10.1007/978-94-007-4549-0-2
36. Barnes PJ (2009) Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 71:451-464. doi: 10.1146/annurev.physiol.010908.163257
37. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352(19):1967-1976
38. Chen Y, Huang P, Ai W, Li X, Guo W, Zhang J, Yang J (2012) Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J Inflamm (Lond) 9:10. doi: 10.1186/1476-9255-9-10
39. Storck EM, Wojciak-Stothard B (2012) Rho GTPases in pulmonary vascular dysfunction. Vasc Pharmacol 58(3):202-210. doi: 10.1016/j.vph.2012.09.004
40. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, Boe DM, Morimoto K, Bowler RP, Day BJ, Janssen WJ, Henson PM, Vandivier RW (2009) Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med 179(11):1011-1021. doi: 10.1164/rccm.200807-1148OC